Akso Health Group valuation and forecast
Explore the models for Akso Health Group, adjust their assumptions and compare your own valuation with the platform's.
Stock price today
Loading chart…
Third-party market data · may be delayed
Fair value per share
Under review: our cash-flow value ($0.00) is 0.00x the share price ($1.19); a gap this wide almost always means a data problem.
Price vs value
Under review: our cash-flow value ($0.00) is 0.00x the share price ($1.19); a gap this wide almost always means a data problem. We'll show the comparison once resolved.
Price history
Loading chart…
Third-party market data · may be delayed
The assumptions
- Free cash flow (TTM, FY2026 Q4)
- -$12.8M
- Less stock-based pay
- $902,820
- Cash flow we value
- $191,829
- Growth, years 1–5 (base)
- %
- Then fading to
- 2.5%
- Discount rate
- 8.5%
- Net cash added
- $170,572
- Diluted shares
- 723M
What would move the value
- Growth 5 points lower
- —
- Growth 5 points higher
- —
- Free-cash-flow margin 1 point lower
- —
- Discount rate 1 point higher
- —
Change in our model value when one input moves, all else equal.
AHG valuation questions
- How does Fundamentalytics value Akso Health Group?
- We use the models that fit Akso Health Group's business and available financial data. Each model has its own assumptions and data requirements. The calculator explains which models are available and lets you adjust their inputs.
Data: SEC EDGAR filings, retrieved Invalid Date. Method: how we value companies. Disclosures: research and recommendations disclosure. Back to Akso Health Group.